D Amp M Pharma Peru Sac ~upd~ Jun 2026

The logistics and distribution operation of the company is structured to ensure of products, with an agile response to the needs of pharmacies, hospitals, and medical clinics in Peru. The company operates under an efficient supply chain model, guaranteeing continuity in the supply of medications.

What is the primary ? (e.g., medical professionals, investors, B2B partners)

Also provides solutions in Ophthalmology (Novoplos line) and Gastrointestinal health (Biocass probiotics). Market Position and Activities

The company's global network is reinforced by its active membership in international business associations, such as the , reflecting its strong ties to the South American pharmaceutical sector. d amp m pharma peru sac

While D amp M Pharma Peru SAC does not publicly disclose its full catalog without a business NDA, industry intelligence points to several core therapeutic areas:

: Biosol LC and various topical treatments for hair and skin health. Mission and Philosophy

In the competitive landscape of the Peruvian pharmaceutical industry, has carved out a significant presence. More than just a commercial name, it is a reflection of an international business vision and a deep commitment to the region's public health. With over a decade of experience in the market, this company has established itself as a strategic ally for the medical community in the country, combining high-quality products with a specialized service philosophy. The logistics and distribution operation of the company

: The company works closely with international partners like Laboratorio Cassará

Guaranteeing the temperature-controlled supply chain remains unbroken from port of entry to final delivery.

D&M Pharma Perú S.A.C. operates under a multi-divisional corporate umbrella. This structure allows the company to handle diverse medical specializations without losing targeted expertise. Mission and Philosophy In the competitive landscape of

According to EMIS (Emerging Markets Information Service), the company employs around 32 people (data as of 2024), classifying it as a small to medium-sized enterprise with a focused yet highly specialized structure.

For D & M Pharma Peru S.A.C., social responsibility begins with its own team. The company promotes policies and programs that strengthen the well-being of its employees, creating a safe and conducive environment for professional development. In parallel, it actively supports the medical community with quality solutions and participates in community health initiatives, promoting sustainable practices that generate value for society.

: Inhaler therapies such as Salbutral (salbutamol) intended to support acute and chronic bronchospasm management. Corporate Structure and Quality Management